Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

ProShares Ultra Nasdaq Biotechnology (NQ:BIB)

40.72 -1.49 (-3.53%)
Official Closing Price Updated: 4:15 PM EDT, Apr 16, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,808
Open 41.68
Bid (Size) 39.76 (3)
Ask (Size) 42.13 (3)
Prev. Close 42.21
Today's Range 40.00 - 41.68
52wk Range 33.77 - 69.56
Shares Outstanding N/A
Dividend Yield 1.50%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Lifeline For 23andMe? Stock Jumps After Court Greenlights Bankruptcy Asset Sale, Retail Weighs Possible Rescue Deals
Stocktwits users spotted a media report about Richard Magides, the director of Singapore-based Zentree Investment and 23andMe's second-largest shareholder, expressing interest in backing a rescue... 
Via Stocktwits
Topics Bankruptcy
Exposures COVID-19 Financial Legal
Tonix Pharma Dominates Retail Biotech Buzz After 1-for-100 Reverse Split, Sentiment Turns Neutral Amid Volatility
Short interest in the stock has grown steadily since mid-December, rising from 0.9% to 8.5% by the end of January, according to Koyfin data. 
Via Stocktwits

Performance

YTD
-20.7%
-20.7%
1 Month
-25.6%
-25.6%
3 Month
-19.9%
-19.9%
6 Month
-38.0%
-38.0%
1 Year
-17.8%
-17.8%

More News

Read More
Small-Cap NRx Pharma’s Stock Draws Heavy Retail Buzz After Securing $27M Funding
Via Stocktwits
Amgen, Inc. Dividend Stock Analysis
Via Talk Markets
Wall Street’s Favorite Biotech Stocks? 3 Names That Could Make You Filthy Rich
Via InvestorPlace
Friday Trades And June Summary
Via Talk Markets
The 7 Best ETFs to Buy to Cover 2023’s Biggest Investing Opportunities
Via InvestorPlace
The 7 Hottest Biotech Stocks to Own in 2023 and Beyond
Via InvestorPlace
Market Briefing For Tuesday, July 5, 2022
Via Talk Markets
Psychedelics Company COMPASS Pathways To Join NASDAQ Biotechnology Index
Via Benzinga
Take A Look At The Top-Performing Biotech ETFs YTD
Via Talk Markets
Exposures COVID-19

Frequently Asked Questions

Is ProShares Ultra Nasdaq Biotechnology publicly traded?
Yes, ProShares Ultra Nasdaq Biotechnology is publicly traded.
What exchange does ProShares Ultra Nasdaq Biotechnology trade on?
ProShares Ultra Nasdaq Biotechnology trades on the Nasdaq Stock Market
What is the ticker symbol for ProShares Ultra Nasdaq Biotechnology?
The ticker symbol for ProShares Ultra Nasdaq Biotechnology is BIB on the Nasdaq Stock Market
What is the current price of ProShares Ultra Nasdaq Biotechnology?
The current price of ProShares Ultra Nasdaq Biotechnology is 40.72
When was ProShares Ultra Nasdaq Biotechnology last traded?
The last trade of ProShares Ultra Nasdaq Biotechnology was at 04/16/25 04:15 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.